Engineers had to calculate the optimal air flow into the chamber to ensure that patients would breathe a full dose each time.

FORBES: Waiting to Inhale

Following a positive interim analysis showing that fractional flow-reserve-guided PCI was superior to optimal medical treatment, an independent Data and Safety Monitoring Board (DSMB) has recommended that patient enrollment in the ongoing FAME II trial be stopped.

FORBES: New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR